We are delighted to announce the finalists for the 2017 Clinical and Research Excellence Awards:
Best Patient Centric Clinical Trial
Braeburn Pharmaceuticals, Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients with Opioid Use Disorder
CK Aspire, Domiciliary Service on behalf of the Salford Lung Study (SLS) sponsored by GlaxoSmithKline (GSK)
Janssen Research & Development, A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 (Palucorcel) in Participants with Geographic Atrophy (PRELUDE)
PPD, CRADLE
Don’t forget to book your place to attend.
Best Patient-Focused Technological Development
AMRA,
AMRA® Profiler Research
CRF Health,
TrialConsent™, electronic informed consent platform
NorthWest EHealth,
Linked Database System
PAREXEL International, Consent+
Don’t forget to book your place to attend.
Best Sponsor-Focused Technological Development
Covance,
Xcellerate® Medical Review
Cytel, East 6.4 Team
goBalto, goBalto Select
IBM Watson Health & Novartis & Highlands Oncology,
Watson Clinical Trial Matching Team
Medidata Solutions, Medidata Balance: Pooling Trial Supplies at Sites
Don’t forget to book your place to attend.
Clinical Partnership of the Year – Sponsored by EBD Group
AstraZeneca Business Development Project Team
Bellerophon Therapeutics and Worldwide Clinical Trials
Medidata Solutions & TESARO
Novartis Pharma; Kenya Medical Research Institute Center for Clinical Research/Strathmore University; Kintampo Health Research Center; Ifakara Health Institute; Division of Clinical Pharmacology at the University of Cape Town; Addis Ababa University/ Regional Bioequivalence Center; African Institute of Biomedical Science and Technology, Clinical Pharmacology Capability Building in Sub-Saharan Africa
Don’t forget to book your place to attend.
Clinical Trial Result of the Year
Centrexion Therapeutics, TRIUMPH – Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
Kiadis Pharma, Evaluation of the safety and efficacy of ATIR101™ in patients with a hematologic malignancy, who received a CD34-selected hematopoietic stem cell transplantation from a haploidentical donor
Kite Pharma, ZUMA-1 Pivotal CAR-T Therapy Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma (NHL)
Radius Health, Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women with Osteoporosis
TESARO, Niraparib NOVA Trial
Don’t forget to book your place to attend.
Excellence in Rare Disease Drug Development
Onxeo, AsiDNA, a first-in-class signal-interfering DNA repair pathway inhibitor for cancer treatment
Retrophin, Phase 2 Study (NCT01613118) of Sparsentan for focal segmental glomerulosclerosis (FSGS)
Tocagen, Toca 511 + Toca FC for recurrent high grade glioma
Don’t forget to book your place to attend.
Most Innovative Clinical Trial Design
Braeburn Pharmaceuticals, A Phase III Trial of CAM2038, a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine Treatment for Adult Outpatients with Opioid Use Disorder
Ipca Laboratories, Evaluation of Efficacy and Safety of Spironolactone + Chlorthalidone Combination in the Treatment of Patients with Essential Hypertension, Pre-diabetes, and Insulin Resistance: A Double-blind, Randomized Comparison with Individual Monotherapies
Ipca Laboratories, Efficacy and Safety of Hydroxychloroquine in Prevention of Diabetes in Patients with Pre-diabetic Dyslipidemia: A Double Blind, Randomized Comparison with Atorvastatin Alone
Multiple Myeloma Research Foundation, CoMMpass ((Relating) Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profiles) study
Tracon Pharmaceuticals (in collaboration with Cytel),
A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib alone in Patients with Advanced Angiosarcoma (TAPPAS)
Don’t forget to book your place to attend.
Most Successful Early Phase Trial (Preclinical & Phase I)
Nektar, NKTR-214 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies
Onxeo, A first-in-human Phase I clinical trial of AsiDNA in patients with metastatic melanoma
Tocagen, Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Don’t forget to book your place to attend.
Pharma/Biotech Product Development Team of the Year – Sponsored by Cytel
ICON/Pfizer Tofa Oral Strategy Team
Retrophin,
Sparsentan Product Development Team
TESARO,
Niraparib Product Development Team
Don’t forget to book your place to attend.
Marquee Award for R&D Excellence
Shortlist will be announced soon.
Don’t forget to book your place to attend.
Lifetime Achievement Award
To be announced on the evening.
Winners will be announced at the awards ceremony and dinner on 5 April, at the State Room in Boston.
Don’t forget to book your place to attend.
Good luck to all of our finalists!
Request a Demo
Client Services
Pharma Report Store